UPDATES
Executive Board 134
Today the Executive Board of the World Health Organisation (WHO) discussed the issue of substandard/spurious/falsely labelled/falsified/counterfeit (SSFFC) medical products. Counterfeit medicines threaten health systems worldwide. Many countries stressed the need for enhanced regulatory capacity to be achieved, in particular, by fostering regulatory convergence. During her opening address on Monday 20 Read more…